AIH

Clinical trials for AIH explained in plain language.

Never miss a new study

Get alerted when new AIH trials appear

Sign up with your email to follow new studies for AIH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug aims to tame autoimmune hepatitis and cut steroid use

Disease control Not yet recruiting

This study tests a drug called inebilizumab in 180 adults with autoimmune hepatitis, a condition where the immune system attacks the liver. The goal is to see if the drug can reduce liver inflammation and allow patients to take lower doses of steroids. Participants will receive e…

Matched conditions: AIH

Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control

Last updated Jun 27, 2026 12:35 UTC

AIH

Get alerted when new AIH trials appear

New drug aims to tame autoimmune hepatitis and cut steroid use